The DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index.
Biopharmaceutical Parameters to Consider in Order to Alter The Fate of Nanocarriers After Oral Delivery
Abstract
Oral route is the most common route for the delivery of drugs because it is simple to implement and improves patient compliance and quality of life. However, oral absorption is limited by various physiological barriers and remains a scientific challenge. Nanometric-sized drug delivery systems are being extensively studied and provide promising potential for oral drug delivery. Many different technological solutions have been proposed to enhance the bioavailability or the targeting of drug after oral administration. To reach these goals, it is important to analyze the biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. In the present review, the gastrointestinal barrier and physiological stress factors with regard to nanocarriers' performance or integrity issues are first described. Second, the different characteristics offered by the nanocarriers (size, surface composition and properties mediated by external factors such as ligands) and their effect on the optimal transport of drug into the bloodstream are discussed. Finally, the integrity issue is discussed in function of the expected role of the nanocarriers: bioavailability enhancement or pharmacological targeting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,805
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
REJMAN, J., OBERLE, V., ZUHORN, I. S., & HOEKSTRA, D. (2004) · Biochemical Journal · doi:10.1042/bj20031253 · Cited by 2,864
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Chithrani, B. D., & Chan, W. C. W. (2007) · Nano Letters · doi:10.1021/nl070363y · Cited by 2,286
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815
Solid lipid nanoparticles for parenteral drug delivery
Wissing, S. A., Kayser, O., & Müller, R. H. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.002 · Cited by 1,495
Cited by
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
McClements, D. J., & Rao, J. (2011) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.559558 · Cited by 1,630
Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623
pH-Responsive Nanoparticles for Drug Delivery
Gao, W., Chan, J. M., & Farokhzad, O. C. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100253e · Cited by 1,025
Nanoparticles for oral delivery: Design, evaluation and state-of-the-art
Date, A. A., Hanes, J., & Ensign, L. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.016 · Cited by 539
Materials for oral delivery of proteins and peptides
Brown, T. D., Whitehead, K. A., & Mitragotri, S. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0156-6 · Cited by 520
Bilia, A. R., Guccione, C., Isacchi, B., Righeschi, C., Firenzuoli, F., & Bergonzi, M. C. (2014) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2014/651593 · Cited by 514
RetractedOral delivery of anticancer drugs: Challenges and opportunities
Thanki, K., Gangwal, R. P., Sangamwar, A. T., & Jain, S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.04.020 · Cited by 499
Review of in vitro digestion models for rapid screening of emulsion-based systems
McClements, D. J., & Li, Y. (2010) · Food & Function · doi:10.1039/c0fo00111b · Cited by 464
A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery
Chen, M.-C., Sonaje, K., Chen, K.-J., & Sung, H.-W. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.087 · Cited by 420
Choi, Y. H., & Han, H.-K. (2018) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-017-0370-4 · Cited by 406
Nanodrugs: pharmacokinetics and safety
Onoue, S., Yamada, S., & Chan, K. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s38378 · Cited by 382
A review: using nanoparticles to enhance absorption and bioavailability of phenolic phytochemicals
Li, Z., Jiang, H., Xu, C., & Gu, L. (2015) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2014.05.010 · Cited by 376
Pharmaceutical nanotechnology for oral delivery of anticancer drugs
Mei, L., Zhang, Z., Zhao, L., Huang, L., Yang, X.-L., Tang, J., & Feng, S.-S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.11.005 · Cited by 373
BCS class IV drugs: Highly notorious candidates for formulation development
Ghadi, R., & Dand, N. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.014 · Cited by 361
Fate of polymeric nanocarriers for oral drug delivery
Plapied, L., Duhem, N., des Rieux, A., & Préat, V. (2011) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2010.12.005 · Cited by 320
Maisel, K., Ensign, L., Reddy, M., Cone, R., & Hanes, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.10.026 · Cited by 319
Jin, Y., Song, Y., Zhu, X., Zhou, D., Chen, C., Zhang, Z., & Huang, Y. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.10.075 · Cited by 301
The Promise of Nanotechnology in Personalized Medicine
Alghamdi, M. A., Fallica, A. N., Virzì, N., Kesharwani, P., Pittalà, V., & Greish, K. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050673 · Cited by 284
Qu, G., Xia, T., Zhou, W., Zhang, X., Zhang, H., Hu, L., Shi, J., Yu, X.-F., & Jiang, G. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00445 · Cited by 275
Polymeric nanoparticle drug delivery technologies for oral delivery applications
Pridgen, E. M., Alexis, F., & Farokhzad, O. C. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1018175 · Cited by 269
Li, Z., & Gu, L. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf404621f · Cited by 96
Amaral, A. C., Saavedra, P. H. V., Oliveira Souza, A. C., de Melo, M. T., Tedesco, A. C., Morais, P. C., Soares Felipe, M. S., & Bocca, A. L. (2019) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2018.11.048 · Cited by 59
Recent progress of micro/nanomotors to overcome physiological barriers in the gastrointestinal tract
Zhang, S., Zhu, C., Huang, W., Liu, H., Yang, M., Zeng, X., Zhang, Z., Liu, J., Shi, J., Hu, Y., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.005 · Cited by 59
Miconazole-loaded nanoparticles coated with hyaluronic acid to treat vulvovaginal candidiasis
Teixeira, A. D. R., Quaresma, A. D. V., Branquinho, R. T., Santos, S. L. E. N., Magalhães, J. T. D., Silva, F. H. R. D., Marques, M. B. D. F., Moura, S. A. L. D., Barboza, A. P. M., Araújo, M. G. D. F., et al. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106508 · Cited by 18
Metadata
- Authors
- Roger, E., Lagarce, F., Garcion, E., & Benoit, J.-P.
- Venue
- Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2010-02
- Volume
- 5
- Issue
- 2
- Pages
- 287-306
- ISSN
- 1743-5889 (ISSN-L)
- 1748-6963
- OpenAlex
- W2017853225
- Cited by
- 324
- References
- 189
- FWCI
- 10.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.